Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 3
1998 1
1999 3
2000 1
2001 1
2003 2
2004 1
2006 1
2009 1
2013 1
2015 1
2016 1
2017 2
2018 1
2019 3
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P-glycoprotein induction and inhibition in the intestine, liver, and kidney.
Asaumi R, Nunoya KI, Yamaura Y, Taskar KS, Sugiyama Y. Asaumi R, et al. Among authors: nunoya ki. CPT Pharmacometrics Syst Pharmacol. 2022 Jul;11(7):919-933. doi: 10.1002/psp4.12807. Epub 2022 Jun 6. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35570332 Free PMC article.
Species Difference in Hydrolysis of an Ester-Type Prodrug of Levodopa in Human and Animal Plasma: Different Contributions of Alpha-1 Acid Glycoprotein.
Kono K, Nunoya KI, Nakamura Y, Bi J, Mukunoki A, Takeo T, Nakagata N, Maeda H, Yamaura Y, Imawaka H, Watanabe H, Maruyama T. Kono K, et al. Among authors: nunoya ki. Mol Pharm. 2022 Sep 5;19(9):3450. doi: 10.1021/acs.molpharmaceut.2c00598. Epub 2022 Jul 28. Mol Pharm. 2022. PMID: 35900112 No abstract available.
Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction.
Asaumi R, Menzel K, Lee W, Nunoya KI, Imawaka H, Kusuhara H, Sugiyama Y. Asaumi R, et al. Among authors: nunoya ki. CPT Pharmacometrics Syst Pharmacol. 2019 Nov;8(11):845-857. doi: 10.1002/psp4.12457. Epub 2019 Sep 5. CPT Pharmacometrics Syst Pharmacol. 2019. PMID: 31420941 Free PMC article.
A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
Ito R, Umehara K, Suzuki S, Kitamura K, Nunoya KI, Yamaura Y, Imawaka H, Izumi S, Wakayama N, Komori T, Anzai N, Akita H, Furihata T. Ito R, et al. Among authors: nunoya ki. Mol Pharm. 2019 Nov 4;16(11):4461-4471. doi: 10.1021/acs.molpharmaceut.9b00519. Epub 2019 Oct 15. Mol Pharm. 2019. PMID: 31573814
Role of human cytochrome P4502A6 in C-oxidation of nicotine.
Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. Among authors: nunoya k. Drug Metab Dispos. 1996 Nov;24(11):1212-7. Drug Metab Dispos. 1996. PMID: 8937855
27 results